Trial Profile
A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischaemic Stroke Patients
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*